Compare MKSI & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MKSI | COO |
|---|---|---|
| Founded | 1961 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 16.5B |
| IPO Year | 1997 | 1994 |
| Metric | MKSI | COO |
|---|---|---|
| Price | $277.74 | $64.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $263.31 | $90.18 |
| AVG Volume (30 Days) | 951.2K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | ★ 55.52 | N/A |
| EPS | ★ 4.37 | 0.66 |
| Revenue | ★ $3,931,000,000.00 | $2,532,800,000.00 |
| Revenue This Year | $15.87 | $6.66 |
| Revenue Next Year | $10.87 | $5.18 |
| P/E Ratio | ★ $64.04 | $97.49 |
| Revenue Growth | 9.62 | ★ 18.41 |
| 52 Week Low | $67.88 | $61.78 |
| 52 Week High | $294.05 | $89.83 |
| Indicator | MKSI | COO |
|---|---|---|
| Relative Strength Index (RSI) | 63.77 | 24.84 |
| Support Level | $208.96 | $64.19 |
| Resistance Level | N/A | $70.01 |
| Average True Range (ATR) | 11.38 | 1.60 |
| MACD | 0.91 | -0.42 |
| Stochastic Oscillator | 62.47 | 7.68 |
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.